Teva Pharmaceut ADR

TEV

(XETRA)

€ 31,46 <%= Resources.Global.txtUp %>

Opdateret 17-05-2013
ISIN: US8816242098

Idag

Market closed

Marked er lukket, åbner klokken 09:00

	08 maj	UPDATE: Teva, Alexza Pharmaceuticals In Inhaler Licensing Pact

	08 maj	Teva Pharmaceutical, Alexza Pharmaceuticals Reach Licensing Pact for Adasuve

	02 maj	UPDATE: Teva Pharmaceutical's Profit Falls on Lower Generic Sales

	02 maj	Teva Net Falls 27% on Lower Generic Sales

	02 maj	Teva Pharmaceutical 1st-Quarter Net Falls 27% on Lower Generic Sales

	01 maj	FDA Approves Teva's Plan B Pill for Women 15 Years of Age and Older Without Prescrption

	24 apr	Teva Creates Specialty-Medicines Division, Names Koremans Unit's CEO

	23 apr	Teva Gets Orphan Drug Designation for XEN402

	10 apr	UPDATE: Some Drug Makers Cut Payments, Meals Provided to Doctors

	10 apr	Some Drug Makers Cut Payments, Meals Provided to Doctors

Konsensusmål

44,97 USD

P/E (2013E)

8,7x

K/I (2013E)

1,47x

Direkte afkast (2013E)

3,0%

Konsensus anbefaling

Sælg

Hold

Køb

Åbn analyse

Kilde: FactSet Research

Ingen beskrivelse

For lav Flash Player version